Disclosures. Abedin:AbbVie, Daichii Sankyo, Servier: Consultancy, Honoraria; Actinium Pharmaceutical, AltruBio, Incyte: Research Funding. Al Malki:Tr1X: Co
Definitive radiotherapy may be considered for lentigo maligna if surgery would be disfiguring. High risk, resected melanoma may be treated with adjuvant radiotherapy, but the…
Amy Y. Chen, M.D., is chief of surgery with City of Hope in Atlanta. Learn about her background and experience treating head and neck cancer…
PURPOSEIn patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), brentuximab vedotin (BV) as monotherapy or combined with either lenalidomide (Len) or rituximab…
The bipartisan investigation of hospital systems purchased by Apollo Global Management and Leonard Green & Partners reinforced the findings of past academic research.
Key PointsFor PCNSL, PFS was favorable with RD-WBRT consolidation.RD-WBRT can be more frequently considered for consolidation in lieu of nonmyeloablative c
Nature Medicine – This analysis of the registry database DESCAR-T of more than 3,000 pediatric and adult patients with hematological malignancies who received CAR Tâcell…
2025 is here and medicine has continued to move away from the utopian vision of our admission essays for medical school. We are spending countless…
Presenter: Elizabeth Nally, BSc, MBBS Presenter: Atulya Aman Khosla, MD, MBBS Presenter: Annalis a Guida, MD Presenter: Alan Pollack, MD, PhD Presenter: Sean Ryan Miller,…
Platform fosters collegial interactions among scientists, but potentially limits interactions beyond the academic community
Adding inotuzumab ozogamicin (InO) to hyper-CVAD and blinatumomab may improve outcomes in newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-ALL). Patients w…
